Walgreens introduces 2025-2026 Respiratory Index to monitor flu and COVID-19 hotspots, utilizing prescription and purchase data.

Walgreens, based in Deerfield, Illinois, has introduced the 2025-2026 Respiratory Index, an innovative online tool that monitors flu and COVID-19 trends countrywide. By utilizing data from prescription medications, testing, and over-the-counter products purchased at Walgreens stores across the nation, this interactive tool offers a thorough analysis of respiratory illness patterns in the United States. Building upon over ten years of knowledge from the Walgreens Flu Index, the new tool aims to provide a holistic understanding of respiratory conditions. This information is beneficial for the general public, healthcare professionals, and researchers to stay informed.